Microsoft word - step therapy doc

Intuit and CVS Caremark are always looking for ways to offer you more choices and help you save money
on your prescriptions. Your plan is designed to help you and your employer maintain affordable prescription
drug coverage, and save on prescription costs by encouraging the use of lower-cost generic drugs. Starting
August 1, 2011, the following pharmacy plan changes will be implemented.
Brand Medications Requiring Use of a Generic First
You can save money by using safe, effective generic medications when possible. According to your
prescription benefit plan, in order for certain brand-name medications to be covered, you will have to try a
generic medication first. The chart below tells you which kinds of drugs require you to use a generic first.
This chart only provides a sample list of generic drug options and may not include all drugs available.
Drug Class
Step 1: You will have to try one of these
Step 2: Before you can try one of these
Condition Treated*
Antihistamines/Combinations
fexofenadine-pseudoephedrine 60 mg/120 mg Proton Pump Inhibitors (PPIs)
Protonix Packets Zegerid Powder for Oral Susp Additionally, for the drug classes shown below, you will have to try a generic medication first, or a preferred brand product in order to receive a non preferred brand medication. (shown in Step 2).
Drug Class

Step 1: You will have to try one
Step 2: Before you can try one of
ACE Inhibitors/Angiotensin II
Receptor Antagonists (ARBs)/
Direct Renin Inhibitors/
Combinations
fosinopril/fosinopril HCTZ lisinopril/lisinopril HCTZ losartan/losartan HCTZ moexipril/moexipril HCTZ quinapril/quinapril HCTZ ramipril trandolapril trandolapril-verapamil ext-rel This list is subject to change. For the latest information, please visit www.caremark.com This page contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers that are not affiliated with CVS Caremark. 106-23177a 051611
Drug Class

Step 1: You will have to try one
Step 2: Before you can try one of
Beta Agonists, Short Acting
Bisphosphonates/Combinations
COX-2 Inhibitors/Nonsteroidal
Anti-Inflammatory (NSAIDs)/
Combinations
HMG-CoA Reductase Inhibitors
(HMGs or Statins)/Combinations
Nasal Steroids
Selective Serotonin Agonists/
Combinations
Sleeping Agents
Urinary Antispasmodics
Enablex Gelnique Oxytrol Sanctura XR Vesicare This list is subject to change. For the latest information, please visit www.caremark.com This page contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers that are not affiliated with CVS Caremark. 106-23177a 051911

Source: http://www.intuitbenefits.com/sites/default/files/health/StepTherapyDetails.pdf

Nccn clinical practice guidelines in oncology (nccn guidelines®) non-hodgkin’s lymphomas

NCCN Guidelines Version 1.2014 Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorders OVERVIEW & DEFINITION · Primary cutaneous CD30+ T-cell lymphoproliferative disorders · Primary cutaneous ALCL (PC-ALCL) (LPDs) represent a spectrum that includes primary cutaneous > Represents about 8% of cutaneous lymphoma cases.b ALCL, lymphomatoid papulosis, and “borderline

2003-241.aug

Combination Leflunomide and Methotrexate (MTX)Therapy for Patients with Active Rheumatoid ArthritisFailing MTX Monotherapy: Open-Label Extension of aRandomized, Double-Blind, Placebo Controlled TrialJOEL KREMER, MARK GENOVESE, GRANT W. CANNON, JACQUES CALDWELL, JOHN CUSH, DANIEL E. FURST, MICHAEL LUGGEN, ED KEYSTONE, JOAN BATHON, ARTHUR KAVANAUGH, ERIC RUDERMAN, PATRICIA COLEMAN, DAVID CURTIS, ELL

Copyright © 2011-2018 Health Abstracts